The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer

Figure 3

Examination of whether our signature is feasible. (a and b). In both the training and test sets, the risk model was highly connected to the prognosis of BC patients. (c and d). The prognostic classification efficiency was good according to the ROC curve data. (e). Our approach outperforms three-gene signatures in terms of accuracy. (f and g). In the risk score distribution, high-risk scores group have worse prognosis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)